9:10am ET
Health and Healthcare
Short Sellers Run for Cover From Major Pharma
The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
PFE Coverage Page 43
11:50am ET
Health and Healthcare
Pfizer Announces Big Changes at the Top
Pfizer shares hit multiyear highs and nearly an all-time in Monday’s session after the pharma giant announced a succession plan for its CEO.
Chris Lange 8:50am ET
Health and Healthcare
Short Sellers Grow More Selective on Major Pharma Stocks
The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
9:55am ET
Health and Healthcare
Short Sellers Back Off Major Pharma Stocks
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
7:10am ET
Health and Healthcare
Major Biopharma Catalysts on September’s FDA Calendar
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
10:05am ET
Health and Healthcare
Pfizer Slips Despite Strong Late-Stage Results
Pfizer shares slipped on Monday despite the company posting positive results from a late-stage tafamidis trial.
Chris Lange 7:25am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Aetna, Analog Devices, Lowe’s, Merck, Pfizer, Plug Power, Qualcomm, Target and More
The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm and Target.
11:10am ET
Health and Healthcare
Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018
Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch.
1:05pm ET
Health and Healthcare
How the FDA Is Fighting the Nationwide EpiPen Shortage
The FDA is extending the expiration dates for certain EpiPens in light of the national shortage ahead of the back-to-school season.
4:01pm ET
Investing
Apple, Caterpillar Dominate the Dow Friday
Caterpillar, Apple, Pfizer, and Cisco were Friday's top-gaining Dow stocks.
11:50am ET
Health and Healthcare
Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive
The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors. Here we identify some of the top health care picks.
10:00am ET
Investing
Current Bull Market Not Over Until It’s Over: 5 US Stocks to Buy
Merrill Lynch now recommends these five outstanding dividend-paying U.S. stocks with solid upside potential.
9:50am ET
Health and Healthcare
Short Sellers Hike Bets in Major Pharma Stocks
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
4:01pm ET
Investing
Disney, Pfizer Keep the Dow Flat Wednesday
The Dow is set to finish essentially flat Wednesday, with Disney and Caterpillar weighing on the index as Pfizer and McDonald's do the heavy lifting.